Background illustration for clinical trials search

Paid Clinical Trials Athens

Discover 1,359 paid clinical trials in Athens, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors

for
Recurrent Classic Hodgkin Lymphoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 12+

Code: NCT05039073

Phase2, Recruiting

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

for
Borderline Resectable Pancreatic Ductal Adenocarcinoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06595160

Recruiting

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

for
Advanced Melanoma
Location: Atlanta GA, Knoxville TN, Jacksonville FL,
Sponsor: Replimune, Inc.

Sex: All

Age: 12+

Code: NCT06264180

Phase3, Recruiting

Study of XB010 in Subjects With Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors,
Location: Atlanta GA, Huntersville NC, Nashville TN, Orlando FL,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06545331

Phase1, Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: Atlanta GA, Newnan GA, Chattanooga TN, Knoxville TN,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

for
Locally Recurrent Skin Squamous Cell Carcinoma,
Location: Atlanta GA, Birmingham AL, Durham NC, Cincinnati OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07042295

Phase2, Recruiting

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

for
Angioimmunoblastic T-cell Lymphoma,
Location: Atlanta GA, Augusta GA, Charleston SC, Winston-Salem NC,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT04803201

Phase2, Recruiting

Zopa Retreatment and Vector Shedding in Adults With RRP

for
Recurrent Respiratory Papillomatosis, Papillomavirus Infection,
Location: Atlanta GA, Cincinnati OH, Bethesda MD
Sponsor: Precigen, Inc

Sex: All

Age: 18+

Code: NCT06538480

Recruiting

Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

for
Malignant Skin Neoplasm, Skin Disorder, Skin Neoplasm
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT07213154

Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Atlanta GA, Knoxville TN, Myrtle Beach SC, Durham NC,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase3, Recruiting

A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma

for
Multiple Myeloma, Smoldering Multiple Myeloma,
Location: Atlanta GA, Denver CO
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06768489

Phase1, Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Atlanta GA, Louisville KY, Orange City FL, Clermont FL,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT04198766

Phase1, Phase2, Recruiting

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Atlanta GA, Nashville TN, Columbus OH
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07441694

Phase1, Recruiting

L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma

for
Locally Advanced Cutaneous Squamous Cell Carcinoma
Location: Atlanta GA, Durham NC, Houston TX, Boston MA, Orange CA
Sponsor: Philogen S.p.A.

Sex: All

Age: 18+

Code: NCT07228442

Phase2, Recruiting

L19IL2/TNF in Patients With Basal Cell Carcinoma

for
Locally Advanced Basal Cell Carcinoma
Location: Atlanta GA, Tampa FL, Houston TX
Sponsor: Philogen S.p.A.

Sex: All

Age: 18+

Code: NCT07227870

Phase2, Recruiting

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

for
Astrocytoma, IDH-Mutant, Grade 2,
Location: Atlanta GA, Charlotte NC, Winston-Salem NC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06860594

Phase1, Recruiting

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

for
Glioblastoma, Recurrent Glioblastoma, GBM
Location: Atlanta GA, Jacksonville FL, Chapel Hill NC, Tampa FL,
Sponsor: CarThera

Sex: All

Age: 18+

Code: NCT05902169

Phase3, Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Atlanta GA, Charlotte NC, Matthews NC, Huntersville NC,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase3, Recruiting

Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics

for
Breast Cancer, Ovarian Cancer
Location: Atlanta GA
Sponsor: Emory University

Sex: Female

Age: 25+

Code: NCT06760507

Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

for
Recurrent Glioblastoma, IDH-Wildtype,
Location: Atlanta GA, Winston-Salem NC, Jacksonville FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05432804

Phase1, Phase2, Recruiting